Key points are not available for this paper at this time.
Globally, cancer drug expenditure exceeds 185 in US dollars (USD) billion, with the United States contributing 75 (USD) billion. Many cancer drug doses are calculated on the basis of body weight or body surface area, which often results in leftover drug in partially used single-dose vials (SDVs). The cost of wasted drug is a huge financial burden on the US health care system. We evaluated the cost savings resulting from the reduction of SDV wastage, achieved through the implementation of automated dose rounding rules in electronic health records (EHRs).
Shah et al. (Mon,) studied this question.